Alzheimer's Disease Trial, Recruiting NCT05582200 Sponsor: The Methodist Hospital Research Institute Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05582200
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Alzheimer's disease:

  • You are between 50 and 90 years old (any sex)
  • You have been diagnosed with Alzheimer's disease according to established research guidelines (confirm with trial site)
  • Your Alzheimer's disease has been rated on a standard scale called the CDR, with a score between 1 and 3, meaning mild to severe stages (confirm with trial site)
  • You speak and understand English or Spanish
  • You are able to understand and agree to take part in the study yourself, or you have a legal representative who can do so on your behalf

For healthy volunteers:

  • You are between 18 and 90 years old
  • A brain scan has shown no abnormal protein buildup associated with Alzheimer's disease
  • You speak and understand English
  • You are able to understand and agree to take part in the study yourself

Who may not be able to join:

For people with Alzheimer's disease:

  • You are unable to have an MRI or PET scan for any reason, including severe fear of enclosed spaces
  • You have had a large stroke, serious brain injury, multiple sclerosis, or another significant brain condition that could affect the study results
  • You are pregnant, or if there is any chance you could be pregnant, you must take a pregnancy test on the day of any PET scan and receive a doctor's approval before proceeding
  • You have had a high level of radiation exposure from research studies in the past 12 months (confirm with trial site)

For healthy volunteers:

  • You are unable to have an MRI or PET scan for any reason, including severe fear of enclosed spaces
  • You have any brain condition, other than ordinary headaches
  • You currently have a significant mental health diagnosis (confirm with trial site)
  • You are currently taking psychiatric medications or anti-seizure medications
  • You have had a substance abuse problem in the past two years
  • You currently have cancer, a serious metabolic condition, an active infection, or heart disease
  • You have active problems with your blood, kidneys, lungs, hormones, or liver — except for a thyroid condition that is already being treated
  • You are pregnant, or if there is any chance you could be pregnant, you must take a pregnancy test on the day of any PET scan and receive a doctor's approval before proceeding
  • You have had a high level of radiation exposure from research studies in the past 12 months (confirm with trial site)
  • If your participation involves a specific medication called selegiline: you have a known allergy to selegiline, or you take certain painkillers (such as meperidine) or certain antidepressants (such as bupropion) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 7134411150

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Methodist Hospital Research Institute
Registry
ClinicalTrials.gov
Start date
20 January 2023
Est. completion
31 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The level of monoamine oxidase-B; The level of translocator protein

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov